Hepatitis C Treatments are Too Expensive for Most Americans; CBCD Reviews the Evidence

Dr. Searson wrote that while new and effective drugs are entering the market, “it is too soon to declare victory. It has even been said that we are only ‘at the end of the beginning’ of the struggle.”

Click Here to Read More on PR Underground…